Peer Review History
| Original SubmissionApril 8, 2022 |
|---|
|
PONE-D-22-10070Adapting waterpipe-specific pictorial health warning labels to the Tunisian context using mixed method approachPLOS ONE Dear Dr. Asfar, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers have raised a number of major concerns. They feel the manuscript should outline a clearly-defined research question, and they request improvements to the reporting of methodological aspects of the study. The reviewers also note concerns about the statistical analyses presented and request re-analyses be completed. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Oct 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Thomas Phillips, PhD Staff Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in your Competing Interests section: The manuscript co-authors and I wish to express that we have no financial or other relationships that might lead to a conflict of interest. All authors have participated in the conception of this report, assisted in revising the manuscript for important intellectual content, and provided final approval of the enclosed report. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 5. We note that Figure 1 includes an image of a participant in the study. As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”. If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Adapting waterpipe-specific pictorial health warning labels to the Tunisian context using mixed method approach Reviewed for PLOS ONE Due: July 21, 2022 The article describes the first study conducted in Tunisia regarding the effectiveness of 16 graphic health warning labels previously developed by an international Delphi study. Using a combination of surveys followed by focus groups, WP smoking and nonsmoking participants (n = 63 total, aged 18-34 years) rated and ranked the HWLs based on their perceived harm, quit motivation, and likelihood to prevent WP smoking initiation. HWLs with highest effectiveness included those showing oral cancers, orally transmitted diseases, and a sick child. Subsequent focus group discussion indicated that health effects impacting a person’s physical appearance and guilt feelings over exposing children to WP smoke were critical factors in effectiveness ranking. Suggestions for improvement to the HWLs effectiveness include using more direct language in local dialect for the text, and rotating images to avoid overexposure. The study provides important information about graphic HWLs for waterpipe in the Tunisian context that can be leveraged for effective tobacco control policy designed to reduce prevalence of WP use in the EMR. The focus group results are presented very well – it is very interesting to see the participant feedback for each warning label. However, methodological detail and strong recommendations based on the evidence obtained for addressing the stubborn perception that WP is a less harmful/less addictive form of combustible tobacco smoking are missing. Tables 2 and 3 are quite confusing and require revision for better clarity. Recommendation: revise and resubmit General criticism The manuscript should be reviewed by a scientific editor: for example, words like “bowel” when “bowl” is meant, need to be corrected. Saying a participant was “in denial” is not a scientific statement, but instead a judgmental one, and should be removed. Introduction • Has Tunisia adopted any warnings for cigarettes or other tobacco? The background mentions that they have not implemented much from the FCTC, but it is unclear whether warnings are on cigarettes or other tobacco. It is mentioned in the conclusions, but perhaps it should be in the introduction? • The authors mentioned that the labels were tailored to the culture. Please provide more detail on how this was done. • Consider including results of the Adetona review: Adetona O, Mok S, Rajczyk J, Brinkman MC, Ferketich AK. The adverse health effects of waterpipe smoking in adolescents and young adults: A narrative review. Tobacco Induced Diseases. 2021;19. • What is meant by a “communication domain”? • Please explain why T4-HWL16 is in the Comparison to Cigarette theme (Theme 4) – it seems to fit better in the “WP Specific Harms” (Theme 3). Methods • Please provide a rationale for the age range you targeted. • Please provide a rationale for including nonsmokers in the study design. • Please provide a rationale for stratifying by gender? • What was the rationale for giving a presentation on the health effects of WP smoking? In practice, such additional information will not be provided when one views a warning label. • It is unclear what people were actually asked in the discussion. The methods talk about the framework, but how the constructs were tapped is unknown. Please provide more detail. • Qualitative coding methods are rather vague. Please provide more detail on what the researchers coded for. Results • There was a different age distribution by WP smoking status (nonsmokers had many more in the two upper age categories). Any comparisons between the groups could be impacted by age. Please discuss the impact of this or if it can be controlled for. • The title for Table 2 should indicate what is being presented in the cells. Overall, the tables need to be revised to improve clarity. It’s also hard to map the label numbers to what is being portrayed. • Please edit Table 2 to include the rating scale (1=strongly disagree, 5 = strongly agree) so that the table can be understood when it stands alone. • For Table 3, the N (%) doesn’t make sense: what is in the cell is not N (%) (unless the percentages are all less than 1%). The ranking % in the last column is not clear. Please better clarify what is being presented. • Please provide a better explanation of what the double asterisks footnote means in Table 3. • Use of the word “theme” is assigned to both the HWL themes (1-4) and the rating categories (1-3). This is confusing. Suggest exclusively using “category” for the ratings. • For better clarity, please make the terminology for the themes used in Figure 1 and the text in pages 13-16 identical. • What does this statement mean? As for placement of HWLs, participants did not report noticeable locations. Discussion • The cited study for the following sentence is inappropriate because it is a secondary analysis of the GYTS focusing on students aged 13-15 years old. Please revise This could be explained by the higher prevalence rate and more intensive pattern of WP use among males compared to females in the EMR [27]. • Please provide a reference to support these statements: Males suffer from WP-related negative health effects and dependence more than females, and therefore these warning messages are more relevant to them. • The logic of why more males rated the addictive nature of WP label as more effective isn’t clear because the reader does not know if the participants are aware of this health disparity; in fact the study data indicate that over half of the participants believe WP smoking is less addictive than cigarette smoking. Please refine. • The studies cited regarding overexposure of HWLs are cigarette smoking studies; thus they do not demonstrate anything for waterpipe. Since overexposure and rotation are important concepts for HWLs, please revise this language to be a recommendation in the face of what is known about cigarette HWLs. • What is meant by “advanced language”? This may be a good place to cite the Flesch Readability scale to make your point. Reviewer #2: This is a mixed methods design that examines how waterpipe tobacco smokers and nonsmokers rated and commented on several health warnings previously developed by the team. Overall, the strengths of this paper include: identifying further warnings that may ultimately be used in a specific geographic location; use of smokers and nonsmokers; providing insightful comments from the study participants both in terms of weaknesses, strengths, and ways to improve warning in various domains, and perhaps most importantly, showing how expert opinions diverge from the intended audience. With the said there are a few issues the authors may which to address. I note these below. 1. Would be useful to provide as supplemental materials the semi-structured script. 2. Any conjecture as to why smokers and nonsmokers do not differ in their evaluations. Also, it would be useful to state why we should focus on nonsmokers (e,g., to prevent uptake and/or susceptibility to use). 3. Describe future plans given that feedback was given as to how to improve the warnings. 4. Methodologically, the warnings were obtained using the Delphi approach. This seems reasonable. However, given the large discrepancies obtained, one wonders if there is another approach that may allow investigators to match what the target audience thinks more closely. For example, one suggestion is the mental models approach. Perhaps this can be added in the discussion section for ways to improve the development of hookah warnings. Reviewer #3: In general, I found this to be a well-written paper on a relevant topic, that could have policy utility in Tunisia as well as in other countries with similar product use. I have a few minor suggestions for the text, and my main comment is that the specific warnings supported by this research, and the implications of this, should be made more explicit in the discussion and conclusions. Minor points: Would it be better to talk about water pipe users than smokers? This was somewhat confusing to me. Is it possible to use more descriptive labels in tables 2 and 3 in order to make them more interpretable for the reader? If not, can the data be summarized and move the tables to appendix materials? Its not clear how the stratification of focus group participants was used for comparison purposes in the focus group analysis. Is there a way to more explicitly integrate findings from the rankings and the focus group discussion? In the discussion, it is mentioned that the rankings were confirmed during focus group discussions, but it is not clear how this assessment was made. Findings from the focus groups are mentioned in the discussion that are not explored in the results section. The discussion should be considering interpretation of findings rather than a presentation of new information. How was the theoretical model called upon in the discussion? Line 386, I believe that the authors meant qualitative – but qualitative research is usually not intended to be representative, as extrapolation from qualitative findings is not intended to be of this type. In the conclusion section, it would be good to see what messages/HWL were supported by this research. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Isaac M. Lipkus Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Adapting waterpipe-specific pictorial health warning labels to the Tunisian context using a mixed method approach PONE-D-22-10070R1 Dear Dr. Asfar, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Nabeel Al-Yateem, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-22-10070R1 Adapting waterpipe-specific pictorial health warning labels to the Tunisian context using a mixed method approach Dear Dr. Asfar: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Nabeel Al-Yateem Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .